Mission Wealth Management LP reduced its holdings in The Clorox Company (NYSE:CLX – Free Report) by 8.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,385 shares of the company’s stock after selling 690 shares during the quarter. Mission Wealth Management LP’s holdings in Clorox were worth $1,199,000 at the end of the most recent quarter.
Several other hedge funds have also recently added to or reduced their stakes in the business. Wealth Group Ltd. bought a new stake in shares of Clorox during the third quarter valued at about $231,000. Intact Investment Management Inc. acquired a new position in Clorox during the 3rd quarter valued at about $75,000. Asset Management One Co. Ltd. raised its position in shares of Clorox by 0.7% during the 3rd quarter. Asset Management One Co. Ltd. now owns 82,210 shares of the company’s stock worth $13,393,000 after buying an additional 593 shares in the last quarter. QRG Capital Management Inc. acquired a new stake in shares of Clorox in the 3rd quarter worth approximately $225,000. Finally, Catalyst Capital Advisors LLC bought a new position in shares of Clorox in the third quarter valued at approximately $54,000. Institutional investors own 78.53% of the company’s stock.
Wall Street Analyst Weigh In
A number of research firms have weighed in on CLX. Wells Fargo & Company upped their target price on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 4th. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and lifted their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Evercore ISI upped their price target on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Clorox has an average rating of “Hold” and a consensus target price of $159.62.
Clorox Stock Performance
Clorox stock opened at $155.90 on Tuesday. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The company has a market cap of $19.21 billion, a P/E ratio of 42.60, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The firm’s 50 day simple moving average is $156.73 and its 200-day simple moving average is $160.44.
Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the company posted $2.16 EPS. As a group, equities research analysts predict that The Clorox Company will post 7.15 EPS for the current year.
Clorox Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.13%. Clorox’s payout ratio is presently 133.33%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- Growth Stocks: What They Are, What They Are Not
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- How to Use Stock Screeners to Find Stocks
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.